Renagel 800 mg (Sevelamer Hydrochloride TABLET) 800 MG

RENAGEL 800 MG tablets contain sevelamer hydrochloride, a phosphate binder used to manage high phosphate levels in the blood. This medication is commonly prescribed for individuals with kidney disease who require phosphate control.

Strength

800 MG

Pack Size

180

Manufacturer / TM Owner

SANOFI-AVENTIS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RENAGEL 800 MG tablets are primarily used to lower phosphate levels in the blood, a condition often seen in patients with kidney disease. By binding to dietary phosphate in the gastrointestinal tract, this medication helps to reduce the amount of phosphate absorbed into the bloodstream. People often ask, 'What is RENAGEL used for?' and the answer is that it is typically used to manage hyperphosphatemia, a condition characterized by elevated phosphate levels.

Side Effects

Common effects of RENAGEL 800 MG tablets may include gastrointestinal discomfort, such as nausea, vomiting, or diarrhea. Some users might also experience constipation or abdominal pain. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare provider.

Precautions & Warnings

RENAGEL 800 MG tablets should be taken as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions to ensure effective phosphate control. Patients should also be aware of any potential allergies to the ingredients in the medication and discuss their medical history with their healthcare provider before starting treatment.

Avoid Interactions

RENAGEL 800 MG tablets may interact with certain medications, including those that require gastrointestinal absorption. It is advisable to take other medications at least one hour before or after taking RENAGEL to avoid potential interactions. Additionally, patients should inform their healthcare provider about all the medications they are currently taking to prevent any adverse effects.

Frequently Asked Questions

RENAGEL is used to lower phosphate levels in the blood, typically in patients with kidney disease.

RENAGEL 800 MG tablets should be taken orally with meals, as directed by a healthcare provider.

Common side effects may include gastrointestinal discomfort, nausea, vomiting, diarrhea, constipation, or abdominal pain.

Yes, RENAGEL may interact with other medications, especially those that require gastrointestinal absorption.

The safety of RENAGEL for long-term use should be discussed with a healthcare provider, who can assess individual needs and risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.